Carisoprodol
Product Images NDC 50436-0705

2 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 50436-0705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carisoprodol 01)

Chemical Structure (Carisoprodol 01)
Chemical structure of Carisoprodol showing the molecular arrangement of its atoms, including carbon (C), hydrogen (H), nitrogen (N), and oxygen (O) atoms with corresponding bonds.*
FDA Label Image

Label Image (Lbl504360705)

Label Image (Lbl504360705)
Carisoprodol 350 mg label for 30 tablets by Unit Dose Services. The label states each tablet contains carisoprodol USP 350 mg and specifies storage instructions for controlled room temperature. Manufacturer is Orient Pharma Co., Ltd., Yunlin, Taiwan. The label includes NDC 50436-0705-1 and notes the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.